Effect of doxycycline‐regulated calnexin and calreticulin expression on specific thrombopoietin productivity of recombinant chinese hamster ovary cells
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
In an attempt to increase the specific thrombopoietin (TPO) productivity (qTPO) of recombinant Chinese hamster ovary (rCHO) cells (CHO‐TPO), the effect of expression level of calnexin (CNX) and calreticulin (CRT) on qTPO was investigated. To control both CNX and CRT expression levels simultaneously, the Tet‐Off system was first introduced in CHO‐TPO cells, and stable Tet‐Off cells (TPO‐Tet‐Off) were screened by luciferase assay. The doxycycline‐regulated CNX and CRT expression system in rCHO cells (TPO‐CNX/CRT) was established by cotransfection of CNX and CRT expression vector and pTK‐Hyg vector into TPO‐Tet‐Off cells and subsequent screening by Western blot analysis of CNX and CRT. The expression levels of CNX and CRT in TPO‐CNX/CRT cells could be tightly controlled by adding different concentrations of doxycycline to a culture medium. Compared with the basal level (2 μg/mL doxycyline), a 2.9‐fold increase in CNX expression and a 2.8‐fold increase in CRT expression were obtained in the absence of doxycycline. This, in turn, resulted in a 1.9‐fold increase in qTPO, not inhibiting cell growth or changing in vivo biological activity of TPO. Taken together, these results demonstrate that a simultaneous overexpression of CNX and CRT can increase the qTPO of rCHO cells. © 2004 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“The Tet-Off cell line contains regulatory elements of tetracycline-controlled transactivator (tTA) and a tTA-dependent promoter, which are virtually silent in the absence of tetracycline (Gossen and Bujard, 1992).”
BackgroundAt least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells
Kozak, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90418-9 · Cited by 1,182 · cited 3×
“The cnx5F primer included a NotI restriction enzyme site, Kozak sequence (Kozak, 1987), and the cnx3 primer included a SalI restriction enzyme site.”
MethodInfluentialKim, T. K., Chung, J. Y., Sung, Y. H., & Lee, G. M. (2001) · Biotechnology and Bioprocess Engineering · doi:10.1007/bf02933001 · Cited by 28
Self-citation
Cited by
Kim, J. Y., Kim, Y.-G., & Lee, G. M. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3758-5 · Cited by 801
Self-citationAdvances in recombinant antibody manufacturing
Kunert, R., & Reinhart, D. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7388-9 · Cited by 417
Gasser, B., Saloheimo, M., Rinas, U., Dragosits, M., Rodríguez-Carmona, E., Baumann, K., Giuliani, M., Parrilli, E., Branduardi, P., Lang, C., et al. (2008) · Microbial Cell Factories · doi:10.1186/1475-2859-7-11 · Cited by 326
The art of CHO cell engineering: A comprehensive retrospect and future perspectives
Fischer, S., Handrick, R., & Otte, K. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.10.015 · Cited by 312
Guidelines to cell engineering for monoclonal antibody production
Rita Costa, A., Elisa Rodrigues, M., Henriques, M., Azeredo, J., & Oliveira, R. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.10.002 · Cited by 178
CHO cell engineering to prevent polypeptide aggregation and improve therapeutic protein secretion
Le Fourn, V., Girod, P.-A., Buceta, M., Regamey, A., & Mermod, N. (2014) · Metabolic Engineering · doi:10.1016/j.ymben.2012.12.003 · Cited by 144
Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells
Mohan, C., Kim, Y., Koo, J., & Lee, G. M. (2008) · Biotechnology Journal · doi:10.1002/biot.200700249 · Cited by 102
“It was observed by our group that controlled PDI overexpression had no effect on the q of a TPO-producing cell line, whereas it only moderately enhanced the q for an antibody-producing cell line [42].”
BackgroundInfluentialMohan, C., Park, S. H., Chung, J. Y., & Lee, G. M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21453 · Cited by 73
“In an attempt to overcome the posttranslational bottleneck, ER-resident chaperones, which assist in the later stages of protein synthesis and folding, have been pointed out as a potential target for increasing the q (Chung et al., 2004; Ellis, 1999; Hsu and Betenbaugh, 1997; Hwang et al., 2003; Kleizen and Braakman, 2…”
BackgroundSelf-citationOnitsuka, M., Kim, W.-D., Ozaki, H., Kawaguchi, A., Honda, K., Kajiura, H., Fujiyama, K., Asano, R., Kumagai, I., Ohtake, H., et al. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3814-1 · Cited by 48
Ha, T. K., Hansen, A. H., Kildegaard, H. F., & Lee, G. M. (2019) · Biotechnology Journal · doi:10.1002/biot.201900130 · Cited by 30
Self-citation
Metadata
- Authors
- Chung, J. Y., Lim, S. W., Hong, Y. J., Hwang, S. O., & Lee, G. M.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2004-01-14
- Volume
- 85
- Issue
- 5
- Pages
- 539-546
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W1964138634
- Cited by
- 72
- References
- 3
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.